nifedipine has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Lin, YS; Tsao, PN; Wei, SC; Wong, JM; Wu, CH; Wu-Tsai, JJ | 1 |
| Azuma, J; Hou, XL; Kinoshita, N; Komatsu, K; Qiu, F; Takahashi, K; Tanaka, K | 1 |
| Belotti, S; Chavant, Y; Chevrier, S; Demarne, F; Dumont, C; Jannin, V; Michenaud, M | 1 |
| Adaramoye, OA; Almeida, MM; Anjos, RM; Araújo, IG; Cavalcante, KV; Medeiros, IA; Oliveira, AP; Oliveira, FA; Silvia, DF; Veras, RC | 1 |
| Egami, S; Fujimura, Y; Hori, S; Ikehata, M; Kishi, H; Kuroda, K; Kusumoto, M; Ohnishi, N; Shin, Y; Takara, K; Tatami, R; Tokuda, N; Tsuchishita, Y; Yamada, S; Yatani, Y; Yokoyama, T; Yoshioka, M | 1 |
| Agu, CE; Chukwu, IJ; Nnedu, EB; Uchendu, IK | 1 |
1 review(s) available for nifedipine and curcumin
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
1 trial(s) available for nifedipine and curcumin
| Article | Year |
|---|---|
Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers.
Topics: Administration, Oral; Adult; Area Under Curve; Cross-Over Studies; Curcuma; Female; Herb-Drug Interactions; Humans; Male; Middle Aged; Nifedipine; Phytotherapy; Plant Extracts; Reference Values; Young Adult | 2008 |
6 other study(ies) available for nifedipine and curcumin
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines.
Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Chemoprevention; Colorectal Neoplasms; Curcumin; Endometrial Neoplasms; Female; Humans; Nifedipine; Pyrazoles; Sulfonamides; Sulindac | 2004 |
Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells.
Topics: Caco-2 Cells; Calcitriol; Cell Survival; Curcuma; Curcumin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Herb-Drug Interactions; Humans; Hydroxylation; Inhibitory Concentration 50; Intestinal Mucosa; Ketoconazole; Nifedipine; Oxidation-Reduction; Plant Extracts; Rhizome; Rifampin; RNA, Messenger; Testosterone | 2007 |
Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity.
Topics: Administration, Oral; Chemistry, Pharmaceutical; Curcumin; Drug Delivery Systems; Excipients; Glycerides; Hydrophobic and Hydrophilic Interactions; Lipids; Nifedipine; Piroxicam; Solubility; Solvents; Surface-Active Agents | 2015 |
Hypotensive and endothelium-independent vasorelaxant effects of methanolic extract from Curcuma longa L. in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Caffeine; Calcium; Calcium Channel Blockers; Curcuma; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethnopharmacology; In Vitro Techniques; Male; Mesenteric Arteries; Methanol; Nifedipine; Phenylephrine; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Solvents; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Combination of aqueous extracts of Curcuma longa (turmeric) and some calcium channel blockers synergistically improves CCl4-induced nephrotoxicity in albino rats.
Topics: Acute Kidney Injury; Amlodipine; Animals; Antioxidants; Calcium Channel Blockers; Carbon Tetrachloride; Curcuma; Disease Models, Animal; Drug Synergism; Kidney; Male; Mice; Nifedipine; Oxidative Stress; Plant Extracts; Rats, Wistar | 2020 |